EP0348910A3

19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors

Abstract

19-Substituted progesterone derivatives and related compounds which are active as 19-hydroxylase inhibitors and useful as antihypertensive agents are described herein. The compounds are prepared using appropriate synthetic pathways which will vary according to the nature of the specific 19-substituted progesterone or related compound desired.

Term

Term ended

Projected expiry passed 27 June 2009, 17.2 years ago.

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during
EP0047016A1	Cites	European Patent Office (EPO)	A	Search report
EP0056000A2	Cites	European Patent Office (EPO)	A	Search report
GB1051693A	Cites	United Kingdom	A	Search report
DE3644358A1	Cites	Germany	A	Search report

40 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims5

Priority claims
Document	Office	Kind	Date
212409	United States of America	–	1988-06-28
21240988	United States of America	A	1988-06-28
21240988	United States of America	A	1988-06-28
212409	–	–	–
US19880212409	–	–	–

Members40

Family members, oldest first
Document	Office	Kind
DK318589D0	Denmark	D0	1989-06-27
NO892678D0	Norway	D0	1989-06-27
IE892086L	Ireland	L	1989-12-28
DK318589A	Denmark	A	1989-12-29
FI893163A	Finland	A	1989-12-29
FI893163L	Finland	L	1989-12-29
NO892678L	Norway	L	1989-12-29
PT90988A	Portugal	A	1989-12-29
EP0348910A2	European Patent Office (EPO)	A2	1990-01-03
AU3712789A	Australia	A	1990-01-04
IL90727D0	Israel	D0	1990-01-18
CN1039593A	China	A	1990-02-14
JPH0248598A	Japan	A	1990-02-19
US4910191A	United States of America	A	1990-03-20
EP0348910A3This record	European Patent Office (EPO)	A3	1990-03-21
HUT51288A	Hungary	A	1990-04-28
ZA894754B	South Africa	B	1990-05-30
KR910000588A	Republic of Korea	A	1991-01-29
AU610473B2	Australia	B2	1991-05-16
PH25714A	Philippines	A	1991-09-18
HU204066B	Hungary	B	1991-11-28
NZ229696A	New Zealand	A	1992-03-26
IL90727A	Israel	A	1993-05-13
CA1321578C	Canada	C	1993-08-24
DK167534B1	Denmark	B1	1993-11-15
NO174511B	Norway	B	1994-02-07
NO174511C	Norway	C	1994-05-18
FI92706B	Finland	B	1994-09-15
PT90988B	Portugal	B	1994-11-30
FI92706C	Finland	C	1994-12-27
EP0348910B1	European Patent Office (EPO)	B1	1995-05-17
AT122681T	Austria	T	1995-06-15
ATE122681T1	Austria	T1	1995-06-15
DE68922660D1	Germany	D1	1995-06-22
ES2075014T3	Spain	T3	1995-10-01
IE66338B1	Ireland	B1	1995-12-27
DE68922660T2	Germany	T2	1996-01-18
CN1033032C	China	C	1996-10-16
JP2729320B2	Japan	B2	1998-03-18
KR0160280B1	Republic of Korea	B1	1998-11-16

47 legal events, as 5 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2009-11-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2009-10-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2009-08-27	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2009-07-22	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2008-12-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-11-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-10-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2008-09-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2004-03-01	Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4	NLV4	EP
2004-02-13	Patent ceasedCeasedPL	PL	CH
2004-02-03	Se: european patent has lapsedLapsedEUG	EUG	EP
2004-01-07	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-01-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-12-31	Be: lapsedLapsedBERE	BERE	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-27	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-06-27	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-07-09	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-06-12	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-06-11	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-06-10	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-06-03	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-05-31	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-01-01	European patent in force as of 2002-01-01IF02	IF02	GB
1996-05-08	No opposition filedOpposition26N	26N	EP
1996-03-22	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
1996-03-22	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
1995-10-01	Definitive protectionFG2A	FG2A	ES
1995-09-29	Validation in greece3016793FG4A	FG4A	GR
1995-07-04	It: translation for a ep patent filedITF	ITF	EP
1995-07-04	It: translation for a ep patent filedITF	ITF	EP
1995-06-22	Corresponds to:REF	REF	EP
1995-06-16	Fr: translation filedET	ET	EP
1995-05-17	Designated contracting statesAK	AK	EP
1995-05-17	Corresponds to:REF	REF	EP
1995-03-31	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
1993-03-31	First examination report despatched17Q	17Q	EP
1990-10-24	Request for examination filed17P	17P	EP
1990-03-21	Designated contracting statesAK	AK	EP
1990-02-01	Search report despatchedORIGINAL CODE: 0009013PUAL	PUAL	EP
1990-01-03	Designated contracting statesAK	AK	EP
1989-11-18	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors

Abstract

Term

Priority claims5

Members40

Over the term

Events

Numbers

Titles3

Classification

Designated states1